Revamping hepatitis C global eradication efforts: towards simplified and enhanced screening, prevention, and treatment

Pan, Calvin Q.; Park, James S.

doi:10.21037/tgh-23-104

Cited by 1 publication

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Importantly, the implementation of TasP appears crucial to reduce the burden of HCV infections [ 350 ]. Besides the dramatic improvement in the treatment of chronic HCV, the DAAs stimulated efforts towards its global elimination [ 358 ]. The absence of an effective HCV vaccine has led to the adoption of the TasP strategy [ 359 ].…”

Section: Prevention Of Hcvmentioning

confidence: 99%

Contemporary Insights into Hepatitis C Virus: A Comprehensive Review

Sallam,

Khalil

2024

Microorganisms

View full text Add to dashboard Cite

Hepatitis C virus (HCV) remains a significant global health challenge. Approximately 50 million people were living with chronic hepatitis C based on the World Health Organization as of 2024, contributing extensively to global morbidity and mortality. The advent and approval of several direct-acting antiviral (DAA) regimens significantly improved HCV treatment, offering potentially high rates of cure for chronic hepatitis C. However, the promising aim of eventual HCV eradication remains challenging. Key challenges include the variability in DAA access across different regions, slightly variable response rates to DAAs across diverse patient populations and HCV genotypes/subtypes, and the emergence of resistance-associated substitutions (RASs), potentially conferring resistance to DAAs. Therefore, periodic reassessment of current HCV knowledge is needed. An up-to-date review on HCV is also necessitated based on the observed shifts in HCV epidemiological trends, continuous development and approval of therapeutic strategies, and changes in public health policies. Thus, the current comprehensive review aimed to integrate the latest knowledge on the epidemiology, pathophysiology, diagnostic approaches, treatment options and preventive strategies for HCV, with a particular focus on the current challenges associated with RASs and ongoing efforts in vaccine development. This review sought to provide healthcare professionals, researchers, and policymakers with the necessary insights to address the HCV burden more effectively. We aimed to highlight the progress made in managing and preventing HCV infection and to highlight the persistent barriers challenging the prevention of HCV infection. The overarching goal was to align with global health objectives towards reducing the burden of chronic hepatitis, aiming for its eventual elimination as a public health threat by 2030.

show abstract

Section: Prevention Of Hcvmentioning

confidence: 99%